Cerebrolysin® is the original porcine-brain-derived peptide complex developed by EVER Neuro Pharma (Austria) in the 1950s and used clinically in 50+ countries for stroke, traumatic brain injury, dementia, and cognitive impairment. It contains biologically active neuropeptides (BDNF, GDNF, NGF, CNTF analogs) and free amino acids that cross the blood-brain barrier to promote neuronal survival, synaptogenesis, and functional recovery. This research-grade lyophilized concentrate is produced under strict GMP conditions from the same pharmaceutical starting material as the clinical product and provided with full analytical documentation.
Key Scientific
- High-purity Cerebrolysin peptide fraction (15% peptides <10 kDa, 85% free amino acids)
- Verified neurotrophic activity equivalent to clinical Cerebrolysin® (Ebewe/EVER Pharma)
- Lyophilized concentrate (215.2 mg solids per vial ≈ 10 mL clinical solution)
- Full Certificate of Analysis (COA) with HPLC, amino acid profile, molecular weight distribution, and in-vitro neuroprotection assay
- Manufactured in GMP-aligned, ISO-compliant facilities
- Ideal for stroke, TBI, Alzheimer’s, Parkinson’s, and neuroregeneration research
Research-Referenced Attributes (Based on clinical & preclinical literature; not therapeutic claims.)
- Meta-analysis of 12 RCTs (n>1,800 stroke patients): 30 mL/day IV × 10–21 days → significant improvement in NIHSS and functional outcome
- Increases BDNF, NGF, and synaptic proteins in ischemic brain tissue
- Phase 2/3 dementia trials: improved cognitive scores (ADAS-cog +2.5–4 points) and global function
- Reduces amyloid-β toxicity and tau phosphorylation in Alzheimer’s models
- Accelerates functional recovery after TBI and spinal cord injury in animals
- Excellent safety profile in >10,000 patients — no serious adverse events beyond mild nausea
Why Researchers Choose Nationwide Peptides Cerebrolysin®
- Exact pharmaceutical-grade composition used in all major clinical trials
- Highest documented neurotrophic potency among research suppliers
- Transparent analytical data (peptide MW profile + BDNF induction assay)
- Trusted by neurology, stroke, dementia, and neuroregeneration laboratories worldwide
- Competitive research pricing with bulk options.
